Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
申请人:N30 Pharmaceuticals, Inc.
公开号:US09067893B2
公开(公告)日:2015-06-30
The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
本发明涉及一种新型二氢嘧啶-2(1H)-酮化合物,可用作S-亚硝基谷胱甘肽还原酶(GSNOR)抑制剂,包括这种化合物的制药组合物以及制备和使用它们的方法。